Administration of UBR597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Murillo Rodríguez, Eric ^a   Palomero Rivero, Marcela ^b   Millán Aldaco, Diana ^b   Arias Carrión, Oscar ^c   Drucker Colín, René ^b  

^a Universidad del Mayab   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DOPAMINE; N OLEOYLETHANOLAMINE; PALMIDROL; AMIDASE; BENZAMIDE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CYCLOHEXYL CARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER; ENDOCANNABINOID; ENZYME INHIBITOR; ETHANOLAMINE DERIVATIVE; FATTY ACID AMIDASE; FATTY-ACID AMIDE HYDROLASE; OLEIC ACID; PALMITIC ACID DERIVATIVE;

ALPHA RHYTHM; ANIMAL EXPERIMENT; ARTICLE; CANNULA; CONTROLLED STUDY; DELTA RHYTHM; DORSAL RAPHE NUCLEUS; DRUG ACTIVITY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FOURIER TRANSFORMATION; HYDROLYSIS; LATERAL HYPOTHALAMUS; MALE; NEUROPHYSIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; RAT; REM SLEEP; SLEEP PATTERN; SLOW WAVE SLEEP; THETA RHYTHM; WAKEFULNESS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HYPOTHALAMUS; METABOLISM; SLEEP;

RATTUS; RATTUS NORVEGICUS;

AMIDOHYDROLASES; ANIMALS; BENZAMIDES; CARBAMATES; DOPAMINE; ENDOCANNABINOIDS; ENZYME INHIBITORS; ETHANOLAMINES; HYPOTHALAMUS; MALE; OLEIC ACIDS; PALMITIC ACIDS; RATS; SLEEP; WAKEFULNESS;

EID: 84855314172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020766     Document Type: Article

References (36)

1. Schmid HH, Schmid PC, Natarajan V, (1996) The N-acylation-phosphodiesterase pathway and cell signalling. Chem Phys Lipids 80: 133-142.
2. Hansen HS, (2010) Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp Neurol 1: 48-55.
3. Ahn K, McKinney MK, Cravatt BF, (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108: 1687-1707.
4. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81.
5. Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, et al. (2003) Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. J Med Chem 47: 4998-5008.
6. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, et al. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313: 352-358.
7. Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, et al. (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12: 21-38.
8. Tarzia G, Duranti A, Tontin A, Piersanti G, Mor M, et al. (2003) Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. J Med Chem 46: 2352-2360.
9. Rodríguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414: 209-212.
10. Gaetani S, Oveisi F, Piomelli D, (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacol 28: 1311-1316.
11. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425: 90-93.
12. Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, et al. (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8: 281-288.
13. Calignano G, La Rana G, Piomelli D, (2001) Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 419: 191-198.
14. Capasso R, Izzo AA, Fezza F, Pinto A, Capasso F, et al. (2001) Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice. Br J Pharmacol 134: 945-950.
15. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, et al. (2005) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67: 15-19.
16. Murillo-Rodríguez E, Vázquez E, Millán-Aldaco D, Palomero-Rivero M, Drucker-Colín D, (2007) Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. Eur J Pharmacol 562: 82-91.
17. Jones BE, (2005) From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 11: 578-586.
18. Llinás RR, Steriade M, (2006) Bursting of thalamic neurons and states of vigilance. J Neurophysiol 95: 3297-308.
19. Steriade M, (2006) Grouping of brain rhythms in corticothalamic systems. Neurosci 137: 1087-106.
20. Dzirasa K, Ribeiro S, Costa R, Santos LM, Lin SC, et al. (2006) Dopaminergic control of sleep-wake states. J Neurosci 26: 10577-10589.
21. Monti JM, Monti D, (2007) The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 11: 113-133.
22. Jones BE, (2005) From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26: 578-586.
23. Paxinos G, Watson C, (2005) The Rat Brain in Stereotaxic Coordinates New York Academic Press.
24. Corsi-Cabrera M, Pérez-Garci E, Del Rio-Portilla Y, Ugalde E, Guevara MA, (2001) EEG bands during wakefulness, slow-wave, and paradoxical sleep as a result of principal component analysis in the rat. Sleep 24: 374-380.
25. Santucci V, Storme JJ, Soubrié P, Le Fur G, (1996) Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci 58: PL103-10.
26. Murillo-Rodríguez E, Sánchez-Alavez M, Navarro L, Martínez-González D, Drucker-Colín R, et al. (1998) Anandamide modulates sleep and memory in rats. Brain Res 812: 270-274.
27. Murillo-Rodríguez E, Cabeza R, Méndez-Díaz M, Navarro L, Prospéro-García O, (2001) Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. Neuroreport 12: 2131-2136.
28. Murillo-Rodríguez E, Blanco-Centurión C, Sánchez C, Piomelli D, Shiromani PJ, (2003) Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26: 943-947.
29. Murillo-Rodríguez E, Désarnaud F, Prospéro-García O, (2006) Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci 1: 30-37.
30. Murillo-Rodríguez E, Millán-Aldaco D, Di Marzo V, Drucker-Colín R, (2008) The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. Neurosci 11: 1-11.
31. Murillo-Rodríguez E, Arias-Carrión O, Sanguino-Rodríguez K, González-Arias M, Haro R, (2009) Mechanisms of sleep-wake cycle modulation. CNS Neurol Disord Drug Targets 8: 245-253.
32. Haber SN, Groenewegen HJ, Grove EA, Nauta WJ, (1985) Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway. J Comp Neurol 235: 322-335.
33. Stratford TR, Wirtshafter D, (1990) Ascending dopaminergic projections from the dorsal raphe nucleus in the rat. Brain Res 511: 173-176.
34. Zahm DS, Heimer L, (1993) Specificity in the efferent projections of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of the core and shell. J Comp Neurol 327: 220-232.
35. Monti JM, Jantos H, (2008) The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 172: 625-646.
36. Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero D, Mechoulam R, Drucker-Colín D, (2008) The non-psychoactive cannabis constituent cannabidiol is a wake-inducing agent. Behav. Neurosci 122: 1378-1382.